Allopurinol preconditioning attenuates renal ischemia/reperfusion injury by inhibiting HMGB1 expression in a rat model

Acta Cirurgica Brasileira

Volumn 31, Issue 3, 2016, Pages 176-182

  Zhou, Jiang Qiao ^a   Qiu, Tao ^a   Zhang, Lu ^a   Chen, Zhong Bao ^a   Wang, Zhi Shun ^a   Ma, Xiao Xiong ^a   Li, Dongyu ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Department of Breast and Thyroid Surgery   (China)

Author keywords

Allopurinol; Apoptosis; Inflammation; Ischemia; Rats; Reperfusion

Indexed keywords

ALLOPURINOL; CASPASE 3; CREATININE; HIGH MOBILITY GROUP B1 PROTEIN; MYELOPEROXIDASE; NITROGEN; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; UREA; PEROXIDASE; PROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLORIMETRY; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY ISCHEMIA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM; TUNEL ASSAY; UNINEPHRECTOMY; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ISCHEMIC PRECONDITIONING; KIDNEY; METABOLISM; PATHOLOGY; PROCEDURES; RANDOMIZATION; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; VASCULARIZATION;

ALLOPURINOL; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; INFLAMMATION; ISCHEMIC PRECONDITIONING; KIDNEY; MALE; PEROXIDASE; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 84962439533     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-865020160030000005     Document Type: Article

References (26)

1. Vallon V, Osswald H. Adenosine receptors and the kidney. Handb Exp Pharmacol. 2009;(193):443-70. PMID: 19639291.
2. Prieto-Moure B, Caraben-Redano A, Aliena-Valero A, Cejalvo D, Toledo AH, Flores-Bellver M, Martinez-Gil N, Toledo-Pereyra LH, Lloris Carsi JM. Allopurinol in renal ischemia. J Invest Surg. 2014;27(5):304-16. PMID: 24914485.
3. Khader A, Yang WL, Kuncewitch M, Prince JM, Marambaud P, Nicastro J, Coppa GF, Wang P. Novel resveratrol analogues attenuate renal ischemic injury in rats. J Surg Res. 2015;193(2):807-15. PMID: 25214260.
4. Jeong EK, Jang HJ, Kim SS, Oh MY, Lee DH, Eom DW, Kang KS, Kwan HC, Ham JY, Park CS, Jang DS, Han DJ. Protective effect of eupatilin against renal ischemia-reperfusion injury in mice. Transplant Proc. 2015;47(3):757-62. PMID: 25891726.
5. Tsung A, Zheng N, Jeyabalan G, Izuishi K, Klune JR, Geller DA, Lotze MT, Lu L, Billiar TR. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol. 2007;81(1):119-28. PMID: 17062605.
6. Rabadi MM, Ghaly T, Goligorksy MS, Ratliff BB. HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol. 2012;303(6):F873-85. PMID: 22759395.
7. Zhu P, Xie L, Ding HS, Gong Q, Yang J, Yang L. High mobility group box 1 and kidney diseases (Review). Int J Mol Med. 2013;31(4):763-8. PMID: 23440289.
8. Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1- related pathologies. Pharmacol Ther. 141(3):347-57. PMID: 24220159.
9. Rabadi MM, Kuo MC, Ghaly T, Rabadi SM, Weber M, Goligorsky MS, Ratliff BB. Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Renal Physiol. 2012;302(6):F730-41. PMID: 22189943.
10. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114(23):2508-16. PMID: 17130343.
11. Lee WY, Koh EJ, Lee SM. A combination of ischemic preconditioning and allopurinol protects against ischemic injury through a nitric oxide-dependent mechanism. Nitric Oxide. 2012;26(1):1-8. PMID: 22119149.
12. Kang SM, Lim S, Song H, Chang W, Lee S, Bae SM, Chung JH, Lee H, Kim HG, Yoon DH, Kim TW, Jang Y, Sung JM, Chung NS, Hwang KC. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol. 2006;535(1-3):212-9. PMID: 16516885.
13. Wen SH, Li Y, Li C, Xia ZQ, Liu WF, Zhang XY, Lei WL, Huang WQ, Liu KX. Ischemic postconditioning during reperfusion attenuates intestinal injury and mucosal cell apoptosis by inhibiting JAK/STAT signaling activation. Shock. 2012;38(4):411-9. PMID: 22777122.
14. Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation:Pathogenesis and treatment. World J Transplant. 2015;5(2):52-67. PMID: 26131407.
15. Lee WY, Lee SM. Synergistic protective effect of ischemic preconditioning and allopurinol on ischemia/reperfusion injury in rat liver. Biochem Biophys Res Commun. 2006;349(3):1087-93. PMID: 16959212.
16. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res. 2008;39(2):169-78. PMID: 18164960.
17. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 1983;35(3):198-204. PMID: 6340272.
18. Allen MB, Billig E, Reese PP, Shults J, Hasz R, West S, Abt PL. Donor hemodynamics as a predictor of outcomes after kidney transplantation from donors after cardiac death. Am J Transplant. 2016 Jan;16(1):181-93. doi: 10.1111/ajt.13432.
19. McCafferty K, Forbes S, Thiemermann C, Yaqoob MM. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech. 2014;7(12):1321-33. PMID: 25481012.
20. Abdallah Y, Kasseckert SA, Iraqi W, Said M, Shahzad T, Erdogan A, Neuhof C, Gündüz D, Schlüter KD, Tillmanns H, Piper HM, Reusch HP, Ladilov Y. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes. J Cell Mol Med. 2011;15(11):2478-85. PMID: 21199327.
21. Bussmann AR, Marton Filho MA, Modolo MP, Modolo RP, Amado P, Domingues MA, Castiglia YM, Modolo NS. Effect of allopurinol on the kidney function, histology and injury biomarker (NGAL, IL 18) levels in uninephrectomised rats subjected to ischaemiareperfusion injury. Acta Cir Bras. 2014;29(8):515-21. PMID: 25140593.
22. Al-Zahrani YA, Al-Harthi SE, Khan LM, El-Bassossy HM, Edris SM, A Sattar MA. The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats. Saudi Pharm J. 2015;23(5):487-98. PMID: 26594114.
23. Shin JH, Chun KS, Na YG, Song KH, Kim SI, Lim JS, Kim GH. Allopurinol protects against ischemia/reperfusion-induced injury in rat urinary bladders. Oxid Med Cell Longev. 2015;2015:906787. PMID: 26491537.
24. Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R, Zatta AJ, Guyton RA, Vinten-Johansen J, Zhao ZQ. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and ha release. Shock. 2008;29(6):761-8. PMID: 18496137.
25. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 1997;272(32):19943–50. PMID: 9242662.
26. Lau A, Wang S, Liu W, Haig A, Zhang ZX, Jevnikar AM. Glycyrrhizic acid ameliorates HMGB1-mediated cell death and inflammation after renal ischemia reperfusion injury. Am J Nephrol. 2014;40(1):84-95. PMID: 25059568.